246 related articles for article (PubMed ID: 18669437)
21. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage?
Roman A
Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322
[No Abstract] [Full Text] [Related]
22. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
Cohen MN
Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
[No Abstract] [Full Text] [Related]
23. Why doctors should worry about preemption.
Curfman GD; Morrissey S; Drazen JM
N Engl J Med; 2008 Jul; 359(1):1-3. PubMed ID: 18596269
[No Abstract] [Full Text] [Related]
24. The federal preemption debate in pharmaceutical labeling product liability actions.
Gross JM; Curry JA
Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
[No Abstract] [Full Text] [Related]
25. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
Basile EM; Gross M
Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
[No Abstract] [Full Text] [Related]
26. Doctor explains why he blew the whistle.
Petersen M
N Y Times Web; 2003 Mar; ():C1, C2. PubMed ID: 12812161
[No Abstract] [Full Text] [Related]
27. Tobacco control and free speech--an American dilemma.
Bayer R; Kelly M
N Engl J Med; 2010 Jan; 362(4):281-3. PubMed ID: 20071696
[No Abstract] [Full Text] [Related]
28. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
Kesselheim AS
Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
[TBL] [Abstract][Full Text] [Related]
29. PLIVA v. Mensing: generic consumers' unfortunate hand.
Lee SB
Yale J Health Policy Law Ethics; 2012; 12(2):209-63. PubMed ID: 23175916
[No Abstract] [Full Text] [Related]
30. FDA's regulation of prescription drug labeling: a role for implied preemption.
Kendrick LC
Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
[No Abstract] [Full Text] [Related]
31. Assessing supplement safety--the FDA's controversial proposal.
Cohen PA
N Engl J Med; 2012 Feb; 366(5):389-91. PubMed ID: 22276780
[No Abstract] [Full Text] [Related]
32. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Schwartz MI
Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
[No Abstract] [Full Text] [Related]
33. Wyeth preemption case ruling sparks labeling confusion.
Allison M
Nat Biotechnol; 2009 May; 27(5):399-400. PubMed ID: 19430423
[No Abstract] [Full Text] [Related]
34. Drug risks and free speech--can Congress ban consumer drug ads?
Shuchman M
N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002
[No Abstract] [Full Text] [Related]
35. Restrictions on the use of prescribing data for drug promotion.
Mello MM; Messing NA
N Engl J Med; 2011 Sep; 365(13):1248-54. PubMed ID: 21812664
[No Abstract] [Full Text] [Related]
36. The future of off-label marketing regulations in the post-Sorrell era.
Iraggi J
Seton Hall Law Rev; 2013; 43(3):1137-63. PubMed ID: 23802338
[No Abstract] [Full Text] [Related]
37. Repackaging cigarettes--will the courts thwart the FDA?
Bayer R; Gostin L; Marcus-Toll D
N Engl J Med; 2012 Nov; 367(22):2065-7. PubMed ID: 23151279
[No Abstract] [Full Text] [Related]
38. Prescribing records and the First Amendment--New Hampshire's data-mining statute.
Post R
N Engl J Med; 2009 Feb; 360(8):745-7. PubMed ID: 19228615
[No Abstract] [Full Text] [Related]
39. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
Leghorn J; Brophy E; Rother P
Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
[No Abstract] [Full Text] [Related]
40. The FDA, preemption, and the Supreme Court.
Glantz LH; Annas GJ
N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]